» Articles » PMID: 9789025

Guanine Nucleotide Exchange Factor GEF115 Specifically Mediates Activation of Rho and Serum Response Factor by the G Protein Alpha Subunit Galpha13

Overview
Specialty Science
Date 1998 Oct 28
PMID 9789025
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Signal transduction pathways that mediate activation of serum response factor (SRF) by heterotrimeric G protein alpha subunits were characterized in transfection systems. Galphaq, Galpha12, and Galpha13, but not Galphai, activate SRF through RhoA. When Galphaq, alpha12, or alpha13 were coexpressed with a Rho-specific guanine nucleotide exchange factor GEF115, Galpha13, but not Galphaq or Galpha12, showed synergistic activation of SRF with GEF115. The synergy between Galpha13 and GEF115 depends on the N-terminal part of GEF115, and there was no synergistic effect between Galpha13 and another Rho-specific exchange factor Lbc. In addition, the Dbl-homology (DH)-domain-deletion mutant of GEF115 inhibited Galpha13- and Galpha12-induced, but not GEF115 itself- or Galphaq-induced, SRF activation. The DH-domain-deletion mutant also suppressed thrombin- and lysophosphatidic acid-induced SRF activation in NIH 3T3 cells, probably by inhibition of Galpha12/13. The N-terminal part of GEF115 contains a sequence motif that is homologous to the regulator of G protein signaling (RGS) domain of RGS12. RGS12 can inhibit both Galpha12 and Galpha13. Thus, the inhibition of Galpha12/13 by the DH-deletion mutant may be due to the RGS activity of the mutant. The synergism between Galpha13 and GEF115 indicates that GEF115 mediates Galpha13-induced activation of Rho and SRF.

Citing Articles

Macrophage regulator of G-protein signaling 12 contributes to inflammatory pain hypersensitivity.

Yuan G, Yang S, Gautam M, Luo W, Yang S Ann Transl Med. 2021; 9(6):448.

PMID: 33850845 PMC: 8039686. DOI: 10.21037/atm-20-5729.


RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.

Li Y, Liu M, Yang S, Fuller A, Eisinger-Mathason T, Yang S Oncogene. 2021; 40(14):2553-2566.

PMID: 33686240 PMC: 8694668. DOI: 10.1038/s41388-020-01599-z.


Histamine-induced biphasic activation of RhoA allows for persistent RhoA signaling.

Zhang J, Nguyen A, Miyamoto S, Brown J, McCulloch A, Zhang J PLoS Biol. 2020; 18(9):e3000866.

PMID: 32881857 PMC: 7494096. DOI: 10.1371/journal.pbio.3000866.


A Gα12-specific Binding Domain in AKAP-Lbc and p114RhoGEF.

Martin J, Cavagnini K, Brawley D, Berkley C, Smolski W, Garcia R J Mol Signal. 2019; 11:3.

PMID: 31051012 PMC: 5345129. DOI: 10.5334/1750-2187-11-3.


Live cell optical assay for precise characterization of receptors coupling to Gα12.

Masuho I, Skamangas N, Martemyanov K Basic Clin Pharmacol Toxicol. 2019; 126 Suppl 6:88-95.

PMID: 30916867 PMC: 6764917. DOI: 10.1111/bcpt.13228.


References
1.
Kozasa T, Jiang X, Hart M, Sternweis P, Singer W, GILMAN A . p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science. 1998; 280(5372):2109-11. DOI: 10.1126/science.280.5372.2109. View

2.
Sah V, Hoshijima M, Chien K, Brown J . Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem. 1996; 271(49):31185-90. DOI: 10.1074/jbc.271.49.31185. View

3.
Hart M, Sharma S, Elmasry N, Qiu R, McCabe P, Polakis P . Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem. 1996; 271(41):25452-8. DOI: 10.1074/jbc.271.41.25452. View

4.
Bence K, Ma W, Kozasa T, Huang X . Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit. Nature. 1997; 389(6648):296-9. DOI: 10.1038/38520. View

5.
Snow B, Antonio L, Suggs S, Gutstein H, Siderovski D . Molecular cloning and expression analysis of rat Rgs12 and Rgs14. Biochem Biophys Res Commun. 1997; 233(3):770-7. DOI: 10.1006/bbrc.1997.6537. View